全文获取类型
收费全文 | 1411155篇 |
免费 | 113347篇 |
国内免费 | 3333篇 |
专业分类
耳鼻咽喉 | 18364篇 |
儿科学 | 46562篇 |
妇产科学 | 41053篇 |
基础医学 | 200747篇 |
口腔科学 | 37701篇 |
临床医学 | 125994篇 |
内科学 | 284449篇 |
皮肤病学 | 33355篇 |
神经病学 | 116935篇 |
特种医学 | 53836篇 |
外国民族医学 | 464篇 |
外科学 | 210577篇 |
综合类 | 32755篇 |
现状与发展 | 3篇 |
一般理论 | 487篇 |
预防医学 | 110022篇 |
眼科学 | 31489篇 |
药学 | 98526篇 |
1篇 | |
中国医学 | 3348篇 |
肿瘤学 | 81167篇 |
出版年
2021年 | 10856篇 |
2019年 | 11664篇 |
2018年 | 16580篇 |
2017年 | 12674篇 |
2016年 | 14262篇 |
2015年 | 16014篇 |
2014年 | 22558篇 |
2013年 | 33397篇 |
2012年 | 45394篇 |
2011年 | 47936篇 |
2010年 | 28163篇 |
2009年 | 27060篇 |
2008年 | 44331篇 |
2007年 | 46837篇 |
2006年 | 47406篇 |
2005年 | 45872篇 |
2004年 | 43759篇 |
2003年 | 41704篇 |
2002年 | 40196篇 |
2001年 | 73013篇 |
2000年 | 74538篇 |
1999年 | 61571篇 |
1998年 | 16993篇 |
1997年 | 15437篇 |
1996年 | 15587篇 |
1995年 | 14794篇 |
1994年 | 13403篇 |
1993年 | 12585篇 |
1992年 | 45841篇 |
1991年 | 43480篇 |
1990年 | 41492篇 |
1989年 | 39559篇 |
1988年 | 36188篇 |
1987年 | 35355篇 |
1986年 | 32865篇 |
1985年 | 31277篇 |
1984年 | 23827篇 |
1983年 | 20028篇 |
1982年 | 12210篇 |
1981年 | 10780篇 |
1979年 | 20703篇 |
1978年 | 14576篇 |
1977年 | 12086篇 |
1976年 | 11364篇 |
1975年 | 11619篇 |
1974年 | 13988篇 |
1973年 | 13536篇 |
1972年 | 12633篇 |
1971年 | 11471篇 |
1970年 | 10912篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Toidi Adekambi Chris C. Ibegbu Stephanie Cagle Ameeta S. Kalokhe Yun F. Wang Yijuan Hu Cheryl L. Day Susan M. Ray Jyothi Rengarajan 《The Journal of clinical investigation》2015,125(5):1827-1838
BACKGROUND. The identification and treatment of individuals with tuberculosis (TB) is a global public health priority. Accurate diagnosis of pulmonary active TB (ATB) disease remains challenging and relies on extensive medical evaluation and detection of Mycobacterium tuberculosis (Mtb) in the patient’s sputum. Further, the response to treatment is monitored by sputum culture conversion, which takes several weeks for results. Here, we sought to identify blood-based host biomarkers associated with ATB and hypothesized that immune activation markers on Mtb-specific CD4+ T cells would be associated with Mtb load in vivo and could thus provide a gauge of Mtb infection.METHODS. Using polychromatic flow cytometry, we evaluated the expression of immune activation markers on Mtb-specific CD4+ T cells from individuals with asymptomatic latent Mtb infection (LTBI) and ATB as well as from ATB patients undergoing anti-TB treatment.RESULTS. Frequencies of Mtb-specific IFN-γ+CD4+ T cells that expressed immune activation markers CD38 and HLA-DR as well as intracellular proliferation marker Ki-67 were substantially higher in subjects with ATB compared with those with LTBI. These markers accurately classified ATB and LTBI status, with cutoff values of 18%, 60%, and 5% for CD38+IFN-γ+, HLA-DR+IFN-γ+, and Ki-67+IFN-γ+, respectively, with 100% specificity and greater than 96% sensitivity. These markers also distinguished individuals with untreated ATB from those who had successfully completed anti-TB treatment and correlated with decreasing mycobacterial loads during treatment.CONCLUSION. We have identified host blood-based biomarkers on Mtb-specific CD4+ T cells that discriminate between ATB and LTBI and provide a set of tools for monitoring treatment response and cure.TRIAL REGISTRATION. Registration is not required for observational studies.FUNDING. This study was funded by Emory University, the NIH, and the Yerkes National Primate Center. 相似文献
43.
C. Lindsay DeVane 《Pharmacotherapy》2016,36(9):953-954
44.
45.
46.
47.
48.
49.
Evaluation of training nurses to perform semi‐automated three‐dimensional left ventricular ejection fraction using a customised workstation‐based training protocol 下载免费PDF全文
50.